These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22998911)

  • 1. Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.
    Zarei S; Frank I; Boorjian SA; Thompson RH; Kim S; Weight C; Tarrell R; Thapa P; Cheville JC
    J Urol; 2012 Nov; 188(5):1706-11. PubMed ID: 22998911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microscopic invasion of perivesical fat by urothelial carcinoma: implications for prognosis and pathology practice.
    Scosyrev E; Yao J; Messing E
    Urology; 2010 Oct; 76(4):908-13; discussion 914. PubMed ID: 20709375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
    BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder.
    Tilki D; Svatek RS; Karakiewicz PI; Novara G; Seitz M; Sonpavde G; Gupta A; Kassouf W; Fradet Y; Ficarra V; Skinner E; Lotan Y; Sagalowsky AI; Stief CG; Reich O; Shariat SF
    J Urol; 2010 Aug; 184(2):470-4. PubMed ID: 20620401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perivesical fat invasion in bladder cancer: implications for prognosis comparing pT2b, pT3a and pT3b stages and consequences for adjuvant chemotherapy indications.
    Neuzillet Y; Lebret T; Molinie V; Yonneau L; Herve JM; Theodore C; Botto H
    BJU Int; 2012 Dec; 110(11):1736-41. PubMed ID: 22998125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of the predictive role of perivesical fat invasion in invasive bladder cancer prognosis in 151 Chinese patients.
    Zhang ZL; Xiong YH; Li YH; Hou GL; Liu ZW; Han H; Qin ZK; Yun JP; Zhou FJ
    Chin Med J (Engl); 2011 Sep; 124(18):2915-9. PubMed ID: 22040502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple adverse histological features increase the odds of under staging T1 bladder cancer.
    Weizer AZ; Wasco MJ; Wang R; Daignault S; Lee CT; Shah RB
    J Urol; 2009 Jul; 182(1):59-65; discussion 65. PubMed ID: 19447443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.
    Kim SP; Frank I; Cheville JC; Thompson RH; Weight CJ; Thapa P; Boorjian SA
    J Urol; 2012 Aug; 188(2):405-9. PubMed ID: 22704101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.
    Patel AR; Cohn JA; Abd El Latif A; Miocinovic R; Steinberg GD; Paner GP; Hansel DE
    J Urol; 2013 Jan; 189(1):53-8. PubMed ID: 23164389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radical cystectomy in the treatment of cancer of the bladder].
    Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Bielsa Carrillo A; García Burgos J; Subirá Ríos D; Castaño González I
    Arch Esp Urol; 2000 Sep; 53(7):619-24. PubMed ID: 11037655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.
    Paner GP; Montironi R; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):113-127. PubMed ID: 28398951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa.
    Sun Z; Zhu GL; Lu C; Guo PT; Huang BJ; Li K; Xu Y; Wang ZN; Xu HM
    Ann Surg; 2009 May; 249(5):768-75. PubMed ID: 19387327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinicopathological study on patients with bladder cancer treated with cystectomy].
    Yamashita S; Taniguchi K; Suzu H; Yushita Y; Sakuragi T; Kanetake H; Shindo K; Saito Y; Hori T; Tasaki T
    Hinyokika Kiyo; 1990 Oct; 36(10):1149-54. PubMed ID: 2264543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.
    Knoedler JJ; Boorjian SA; Tollefson MK; Cheville JC; Thapa P; Tarrell RF; Frank I
    BJU Int; 2014 Dec; 114(6):832-6. PubMed ID: 24119219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.